Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

High burden and seasonal variation of paediatric scabies and pyoderma prevalence in The Gambia: A cross-sectional study.

Armitage EP, Senghore E, Darboe S, Barry M, Camara J, Bah S, Marks M, Cerami C, Roca A, Antonio M, Turner CE, de Silva TI.

PLoS Negl Trop Dis. 2019 Oct 14;13(10):e0007801. doi: 10.1371/journal.pntd.0007801. [Epub ahead of print]

2.

Community-acquired Invasive Bacterial Disease in Urban Gambia, 2005-2015: A Hospital-based Surveillance.

Darboe S, Okomo U, Muhammad AK, Ceesay B, Jallow M, Usuf E, Tweed S, Akpalu E, Kwambana-Adams B, Kariuki S, Antonio M, Bradbury RS, Forrest K, de Silva TI, Lawal BJ, Nwakanma D, Secka O, Roca A.

Clin Infect Dis. 2019 Sep 5;69(Supplement_2):S105-S113. doi: 10.1093/cid/ciz463.

3.

Complexities in predicting the immunogenicity of live attenuated influenza vaccines.

Lindsey BB, Höschler K, de Silva TI.

Clin Infect Dis. 2019 Aug 14. pii: ciz773. doi: 10.1093/cid/ciz773. [Epub ahead of print] No abstract available.

4.

Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.

de Lima DS, Cardozo LE, Maracaja-Coutinho V, Suhrbier A, Mane K, Jeffries D, Silveira ELV, Amaral PP, Rappuoli R, de Silva TI, Nakaya HI.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):17121-17126. doi: 10.1073/pnas.1822046116. Epub 2019 Aug 9.

5.

Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study.

Lindsey BB, Jagne YJ, Armitage EP, Singanayagam A, Sallah HJ, Drammeh S, Senghore E, Mohammed NI, Jeffries D, Höschler K, Tregoning JS, Meijer A, Clarke E, Dong T, Barclay W, Kampmann B, de Silva TI.

Lancet Respir Med. 2019 Aug;7(8):665-676. doi: 10.1016/S2213-2600(19)30086-4. Epub 2019 Jun 21.

6.

Prevalence of Panton-Valentine Leukocidin (PVL) and Antimicrobial Resistance in Community-Acquired Clinical Staphylococcus aureus in an Urban Gambian Hospital: A 11-Year Period Retrospective Pilot Study.

Darboe S, Dobreniecki S, Jarju S, Jallow M, Mohammed NI, Wathuo M, Ceesay B, Tweed S, Basu Roy R, Okomo U, Kwambana-Adams B, Antonio M, Bradbury RS, de Silva TI, Forrest K, Roca A, Lawal BJ, Nwakanma D, Secka O.

Front Cell Infect Microbiol. 2019 May 22;9:170. doi: 10.3389/fcimb.2019.00170. eCollection 2019.

7.

Genomic and Epidemiological Evidence of a Dominant Panton-Valentine Leucocidin-Positive Methicillin Resistant Staphylococcus aureus Lineage in Sri Lanka and Presence Among Isolates From the United Kingdom and Australia.

McTavish SM, Snow SJ, Cook EC, Pichon B, Coleman S, Coombs GW, Pang S, Arias CA, Díaz L, Boldock E, Davies S, Udukala M, Kearns AM, Siribaddana S, de Silva TI.

Front Cell Infect Microbiol. 2019 Apr 26;9:123. doi: 10.3389/fcimb.2019.00123. eCollection 2019.

8.

A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.

Miller PDE, de Silva TI, Leonard H, Anthias C, Hoschler K, Goddard K, Peggs K, Madrigal A, Snowden JA.

Vaccine. 2019 Jan 14;37(3):452-457. doi: 10.1016/j.vaccine.2018.11.061. Epub 2018 Dec 13.

PMID:
30554797
9.

The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review.

Lindsey BB, Armitage EP, Kampmann B, de Silva TI.

Lancet Infect Dis. 2019 Apr;19(4):e110-e119. doi: 10.1016/S1473-3099(18)30490-0. Epub 2018 Dec 12. Review. Erratum in: Lancet Infect Dis. 2019 Jun;19(6):e187.

10.

Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma.

James KL, de Silva TI, Brown K, Whittle H, Taylor S, McVean G, Esbjörnsson J, Rowland-Jones SL.

J Virol. 2018 Dec 10;93(1). pii: e00677-18. doi: 10.1128/JVI.00677-18. Print 2019 Jan 1.

11.

Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.

Miller PDE, Forster AS, de Silva TI, Leonard H, Anthias C, Mayhew M, Klammer M, Paskar S, Hurst E, Peggs K, Madrigal A, Snowden JA.

BMJ Open. 2018 Aug 8;8(8):e021222. doi: 10.1136/bmjopen-2017-021222.

12.

Potential impact of influenza vaccine roll-out on antibiotic use in Africa.

Knight GM, Clarkson M, de Silva TI.

J Antimicrob Chemother. 2018 Aug 1;73(8):2197-2200. doi: 10.1093/jac/dky172.

13.

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.

Armitage EP, Camara J, Bah S, Forster AS, Clarke E, Kampmann B, de Silva TI.

Vaccine. 2018 Mar 20;36(13):1772-1780. doi: 10.1016/j.vaccine.2018.02.037. Epub 2018 Feb 23.

14.

HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.

de Silva TI, Leligdowicz A, Carlson J, Garcia-Knight M, Onyango C, Miller N, Yindom LM, Hué S, Jaye A, Dong T, Cotten M, Rowland-Jones SL.

AIDS. 2018 Mar 27;32(6):709-714. doi: 10.1097/QAD.0000000000001753.

15.

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.

Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A, Snowden JA.

Bone Marrow Transplant. 2017 Jul;52(7):1082. doi: 10.1038/bmt.2017.87.

PMID:
28677683
16.

Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity.

de Silva TI, Gould V, Mohammed NI, Cope A, Meijer A, Zutt I, Reimerink J, Kampmann B, Hoschler K, Zambon M, Tregoning JS.

J Immunol Methods. 2017 Oct;449:1-6. doi: 10.1016/j.jim.2017.06.008. Epub 2017 Jun 21.

17.

Value of immunogenicity studies of influenza vaccine in resource-limited settings.

de Silva TI, Kampmann B.

Lancet Glob Health. 2017 Mar;5(3):e274. doi: 10.1016/S2214-109X(17)30038-4. No abstract available.

18.

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.

Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A, Snowden JA.

Bone Marrow Transplant. 2017 May;52(5):775-777. doi: 10.1038/bmt.2016.362. Epub 2017 Jan 23. No abstract available. Erratum in: Bone Marrow Transplant. 2017 Jul;52(7):1082.

19.

Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection.

Garcia-Knight MA, Slyker J, Payne BL, Pond SL, de Silva TI, Chohan B, Khasimwa B, Mbori-Ngacha D, John-Stewart G, Rowland-Jones SL, Esbjörnsson J.

Sci Rep. 2016 Jul 12;6:29536. doi: 10.1038/srep29536.

20.

Predicting the extinction of HIV-2 in rural Guinea-Bissau.

Fryer HR, Van Tienen C, Van Der Loeff MS, Aaby P, Da Silva ZJ, Whittle H, Rowland-Jones SL, de Silva TI.

AIDS. 2015 Nov 28;29(18):2479-86. doi: 10.1097/QAD.0000000000000844.

21.

Full-length sequence of KIR3DL1*0310102 detected in DNA samples from West Africa.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Oct;86(4):312-3. doi: 10.1111/tan.12622. Epub 2015 Jul 22.

PMID:
26198408
22.

KIR3DL1*0040102 – a novel three-domain KIR subtype isolated from donors of African descent.

Yindom LM, James K, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Sep;86(3):220-1. doi: 10.1111/tan.12610. Epub 2015 Jul 22.

PMID:
26197884
23.

A novel KIR3DL1*0150103 subtype identified in West Africa.

Yindom LM, James K, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Jul;86(1):70-1. doi: 10.1111/tan.12570. Epub 2015 Apr 27.

PMID:
26095636
24.

KIR3DL1*0250103: a novel three-domain KIR allele isolated in West African samples.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Aug;86(2):150-1. doi: 10.1111/tan.12590. Epub 2015 Jun 4.

PMID:
26040558
25.

Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.

Jayasooriya S, de Silva TI, Njie-jobe J, Sanyang C, Leese AM, Bell AI, McAulay KA, Yanchun P, Long HM, Dong T, Whittle HC, Rickinson AB, Rowland-Jones SL, Hislop AD, Flanagan KL.

PLoS Pathog. 2015 Mar 27;11(3):e1004746. doi: 10.1371/journal.ppat.1004746. eCollection 2015 Mar.

26.

Identification of a novel three-domain KIR allele: KIR3DL1*087 using high-resolution molecular techniques.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Feb;85(2):153-4. doi: 10.1111/tan.12502.

PMID:
25626614
27.

KIR3DL1*0250102: a novel three-domain KIR subtype identified in West Africa.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2015 Feb;85(2):151-2. doi: 10.1111/tan.12501.

PMID:
25626613
28.

Cutaneous leishmaniasis acquired during a brief visit to Cyprus.

de Silva TI, Debroy Kidambi A, Green ST, Mahadeva U, Mcgregor AC, Levy M, Hardcastle N.

J Infect. 2015 Mar;70(3):314-6. doi: 10.1016/j.jinf.2014.11.001. Epub 2014 Nov 15. No abstract available.

PMID:
25447711
29.

Complete genomic sequence of KIR3DL1*0150102.

Yindom LM, Wong G, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Dec;84(6):595-6. doi: 10.1111/tan.12458. Epub 2014 Oct 28.

PMID:
25352058
30.

Isolation of full-length genomic sequences of the KIR3DL1*0040103 allele from African donors using sequence-based techniques.

Yindom LM, James K, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Dec;84(6):594-5. doi: 10.1111/tan.12455. Epub 2014 Oct 27.

PMID:
25346225
31.

Description of a novel KIR3DL1*0150211 allele isolated using molecular techniques.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Dec;84(6):596-7. doi: 10.1111/tan.12466. Epub 2014 Oct 27.

PMID:
25345557
32.

Genomic full length sequence of a novel killer-cell immunoglobulin-like receptor, KIR3DL1*0010103 identified by sequencing.

Yindom LM, James K, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Nov;84(5):520-1. doi: 10.1111/tan.12438. Epub 2014 Sep 12.

PMID:
25220848
33.

A new variant of killer-cell immunoglobulin-like receptor KIR3DL1*03101 isolated using sequence-based techniques.

Yindom LM, Wong G, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Nov;84(5):521-2. doi: 10.1111/tan.12431. Epub 2014 Sep 12.

PMID:
25220356
34.

Full-length KIR3DL1*022 detected in an African donor.

Yindom LM, James K, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Oct;84(4):427-9. doi: 10.1111/tan.12417. Epub 2014 Aug 11.

PMID:
25113032
35.

A novel KIR3DL1*0200102 allele isolated from a West African donor by sequence-based typing.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Apr;83(4):305-6. doi: 10.1111/tan.12303. Epub 2014 Feb 7.

PMID:
24641505
36.

Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines.

de Silva TI, Green ST, Cole J, Stone BJ, Dockrell DH, Vedio AB.

J Infect. 2014 Apr;68(4):397-9. doi: 10.1016/j.jinf.2013.12.009. Epub 2013 Dec 31. No abstract available.

PMID:
24384506
37.

Full-length sequence of KIR3DL1*01501 allele found in Sub-Saharan Africa by long-range sequencing.

Yindom LM, de Silva TI, Rowland-Jones SL.

Tissue Antigens. 2014 Feb;83(2):126-7. doi: 10.1111/tan.12252. Epub 2013 Nov 28.

PMID:
24286173
38.

Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.

de Silva TI, Peng Y, Leligdowicz A, Zaidi I, Li L, Griffin H, Blais ME, Vincent T, Saraiva M, Yindom LM, van Tienen C, Easterbrook P, Jaye A, Whittle H, Dong T, Rowland-Jones SL.

Blood. 2013 May 23;121(21):4330-9. doi: 10.1182/blood-2012-12-472787. Epub 2013 Apr 4.

PMID:
23558015
39.

Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic.

de Silva TI, van Tienen C, Onyango C, Jabang A, Vincent T, Loeff MF, Coutinho RA, Jaye A, Rowland-Jones S, Whittle H, Cotten M, Hué S.

AIDS. 2013 Jan 2;27(1):125-34. doi: 10.1097/QAD.0b013e32835ab12c.

PMID:
23032414
40.

Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection.

Daigneault M, De Silva TI, Bewley MA, Preston JA, Marriott HM, Mitchell AM, Mitchell TJ, Read RC, Whyte MK, Dockrell DH.

PLoS Pathog. 2012;8(7):e1002814. doi: 10.1371/journal.ppat.1002814. Epub 2012 Jul 19.

41.

Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau.

van Tienen C, de Silva TI, Alcantara LC, Onyango CO, Jarju S, Gonçalves N, Vincent T, Aaby P, Whittle H, Schim van der Loeff M, Cotten M.

PLoS Negl Trop Dis. 2012;6(6):e1690. doi: 10.1371/journal.pntd.0001690. Epub 2012 Jun 12.

42.

Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.

de Silva TI, Aasa-Chapman M, Cotten M, Hué S, Robinson J, Bibollet-Ruche F, Sarge-Njie R, Berry N, Jaye A, Aaby P, Whittle H, Rowland-Jones S, Weiss R.

J Virol. 2012 Jan;86(2):930-46. doi: 10.1128/JVI.06126-11. Epub 2011 Nov 9.

43.

Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.

van Tienen C, McConkey SJ, de Silva TI, Cotten M, Kaye S, Sarge-Njie R, da Costa C, Gonçalves N, Parker J, Vincent T, Jaye A, Aaby P, Whittle H, Schim van der Loeff M.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):584-90. doi: 10.1089/AID.2011.0219. Epub 2012 Mar 9.

PMID:
22066980
44.

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

Peterson K, Jallow S, Rowland-Jones SL, de Silva TI.

AIDS Res Treat. 2011;2011:463704. doi: 10.1155/2011/463704. Epub 2011 Feb 9.

45.

HIV-1 subtype distribution in the Gambia and the significant presence of CRF49_cpx, a novel circulating recombinant form.

de Silva TI, Turner R, Hué S, Trikha R, van Tienen C, Onyango C, Jaye A, Foley B, Whittle H, Rowland-Jones SL, Cotten M.

Retrovirology. 2010 Oct 9;7:82. doi: 10.1186/1742-4690-7-82.

46.

HIV-2: the forgotten AIDS virus.

de Silva TI, Cotten M, Rowland-Jones SL.

Trends Microbiol. 2008 Dec;16(12):588-95. doi: 10.1016/j.tim.2008.09.003. Epub 2008 Oct 27. Review.

PMID:
18964021
47.

HIV-1 infection and the kidney: an evolving challenge in HIV medicine.

de Silva TI, Post FA, Griffin MD, Dockrell DH.

Mayo Clin Proc. 2007 Sep;82(9):1103-16. Review.

PMID:
17803878
48.

The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection.

de Silva TI, Cope A, Goepel J, Greig JM.

J Infect. 2007 Apr;54(4):e207-10. Epub 2006 Dec 29.

PMID:
17197031

Supplemental Content

Loading ...
Support Center